MENLO PARK, Calif.,
May 12, 2016 /PRNewswire/
-- BioPharmX Corporation (NYSE MKT: BPMX), a specialty
pharmaceutical company developing products for the dermatology and
women's health markets, today announced the resignation of
James Pekarsky, the company's
chairman, chief executive officer and treasurer.
President, co-founder and Director Anja
Krammer will continue to manage the company, a role she has
played since BioPharmX was established. CFO Greg Kitchener will assume the responsibilities
of treasurer.
"The board appreciates Jim's role in launching BioPharmX and his
leadership in bringing the company to where it is today," said
independent Director Michael
Hubbard, the company's newly appointed chairman. "We are
confident in Anja's continued leadership and the company's
strategic direction as we bring novel new products to grow the
company's focus on dermatology."
About BioPharmX® Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based
specialty pharmaceutical company that seeks to provide products
through proprietary platform technologies for prescription,
over-the-counter and supplement applications in dermatology and
women's health. To learn more about BioPharmX, visit
www.BioPharmX.com.
For further information:
Nina
Brauer
Senior Manager, Marketing & Communications
nbrauer@biopharmx.com, (650) 889-5030
or
Jeffrey Awalt, Investor
Relations
investors@biopharmx.com, (713) 825-3565
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-ceo-steps-down-board-appoints-independent-director-to-serve-as-chairman-300267940.html
SOURCE BioPharmX Corporation